Obsessive-compulsive disorder epidemiology and demographics: Difference between revisions
m (Bot: Removing from Primary care) |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Obsessive-compulsive disorder}} | {{Obsessive-compulsive disorder}} | ||
{{CMG}}; {{AE}} {{Sonya}}, [[User:Abhishek Reddy|Abhishek Reddy]], {{KS}}, {{USAMA}} | {{CMG}}; {{AE}} {{Priyanka}}{{Sonya}}, [[User:Abhishek Reddy|Abhishek Reddy]], {{KS}}, {{USAMA}} | ||
==Overview== | ==Overview== | ||
Line 14: | Line 14: | ||
*A 2008 study suggests OCD symptoms in Japanese patients are similar to those found in Western countries, proving that, contrary to prior hypotheses, the disorder transcends culture and geography.<ref>Matsunaga, H.; Maebayashi, K., Hayashida, K., Okino, K., Matsui, T., Iketani, T., Kiriike, N., Stein, D. J. (1 February 2008). "Symptom Structure in Japanese Patients With Obsessive-Compulsive Disorder". American Journal of Psychiatry 165 (2): 251–253. doi:10.1176/appi.ajp.2007.07020340. PMID 18006873. Retrieved 25 January 2012.</ref> | *A 2008 study suggests OCD symptoms in Japanese patients are similar to those found in Western countries, proving that, contrary to prior hypotheses, the disorder transcends culture and geography.<ref>Matsunaga, H.; Maebayashi, K., Hayashida, K., Okino, K., Matsui, T., Iketani, T., Kiriike, N., Stein, D. J. (1 February 2008). "Symptom Structure in Japanese Patients With Obsessive-Compulsive Disorder". American Journal of Psychiatry 165 (2): 251–253. doi:10.1176/appi.ajp.2007.07020340. PMID 18006873. Retrieved 25 January 2012.</ref> | ||
*It has been alleged that sufferers are generally of above-average [[intelligence (trait)|intelligence]], as the disorder necessitates complicated thinking patterns. | *It has been alleged that sufferers are generally of above-average [[intelligence (trait)|intelligence]], as the disorder necessitates complicated thinking patterns. | ||
==Overview== | |||
==Epidemiology and Demographics== | |||
===Incidence=== | |||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
===Prevalence=== | |||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | |||
===Case-fatality rate/Mortality rate=== | |||
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | |||
*The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | |||
===Age=== | |||
*Patients of all age groups may develop [disease name]. | |||
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | |||
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age. | |||
*[Chronic disease name] is usually first diagnosed among [age group]. | |||
*[Acute disease name] commonly affects [age group]. | |||
===Race=== | |||
*There is no racial predilection to [disease name]. | |||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | |||
===Gender=== | |||
*[Disease name] affects men and women equally. | |||
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. | |||
===Region=== | |||
*The majority of [disease name] cases are reported in [geographical region]. | |||
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | |||
===Developed Countries=== | |||
===Developing Countries=== | |||
==References== | ==References== |
Revision as of 16:40, 23 April 2021
Obsessive-compulsive disorder Microchapters |
Differentiating Obsessive-Compulsive Disorder from other Diseases |
---|
Obsessive-Compulsive Disorder due to Another Medical Condition |
Diagnosis |
Treatment |
Case Studies |
Obsessive-compulsive disorder epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Obsessive-compulsive disorder epidemiology and demographics |
FDA on Obsessive-compulsive disorder epidemiology and demographics |
CDC on Obsessive-compulsive disorder epidemiology and demographics |
Obsessive-compulsive disorder epidemiology and demographics in the news |
Blogs on Obsessive-compulsive disorder epidemiology and demographics |
Directions to Hospitals Treating Obsessive-compulsive disorder |
Risk calculators and risk factors for Obsessive-compulsive disorder epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyanka Kumari, M.B.B.S[2]Sonya Gelfand, Abhishek Reddy, Kiran Singh, M.D. [3], Usama Talib, BSc, MD [4]
Overview
Once believed to be rare, OCD was found to have a lifetime prevalence of 2,300 per 100,000 (2.3%) of the overall population. The twelve month prevalence of OCD is 1,200 per 100,000 (1.2%) of the overall population.[1][2] Discovery of effective treatments and education of patients and health care providers have significantly increased the identification of individuals with OCD. International studies have shown a similar incidence and prevalence of OCD worldwide.
Epidemiology and Demographics
- The lifetime prevalence of obsessive compulsive disorder is 2,300 per 100,000 (2.3%), though many cases of OCD go under-treated in primary care settings.[2][3]
- The twelve month prevalence of obsessive compulsive disorder is 1,200 per 100,000 (1.2%) of the overall population.[1]
- The lifetime prevalence of OCD is higher for individuals who have not graduated high school (3.4%) than for those who have (1.9%). However, the lifetime prevalence is higher for those who graduate with a college degree (3.1%) than for those who have minimal college background (2.4%).
- The onset of OCD averages at 19.5 years old, but usually ranges from the late teenage years until the mid-20s in both sexes, however the age of onset for males tends to be younger in males than that in females.[4]
- A 2008 study suggests OCD symptoms in Japanese patients are similar to those found in Western countries, proving that, contrary to prior hypotheses, the disorder transcends culture and geography.[5]
- It has been alleged that sufferers are generally of above-average intelligence, as the disorder necessitates complicated thinking patterns.
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ 1.0 1.1 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
- ↑ 2.0 2.1 Hirschtritt ME, Bloch MH, Mathews CA (2017). "Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment". JAMA. 317 (13): 1358–1367. doi:10.1001/jama.2017.2200. PMID 28384832.
- ↑ Osland S, Arnold PD, Pringsheim T (2018). "The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study". Psychiatry Res. 268: 137–142. doi:10.1016/j.psychres.2018.07.018. PMID 30025284.
- ↑ Antony, M. M.; F. Downie & R. P. Swinson. "Diagnostic Issues and Epidemiology in Obsessive-Compulsive Disorder". in Obsessive-Compulsive Disorder: Theory, Research, and Treatment, eds. M. M. Antony; S. Rachman; M. A. Richter & R. P. Swinson. New York: The Guilford Press, 1998, pp. 3-32.
- ↑ Matsunaga, H.; Maebayashi, K., Hayashida, K., Okino, K., Matsui, T., Iketani, T., Kiriike, N., Stein, D. J. (1 February 2008). "Symptom Structure in Japanese Patients With Obsessive-Compulsive Disorder". American Journal of Psychiatry 165 (2): 251–253. doi:10.1176/appi.ajp.2007.07020340. PMID 18006873. Retrieved 25 January 2012.